In the CIN subtype, we observed amplifications of CCND1, CCNE1, ERBB2, FGFR2, KRAS, MYC, PIK3CA and JAK2, and a deletion of PTEN among the 43 genes included in the Next-Generation Sequencing (NGS) panel. This evidence concerns the gene FGFR2 and cervical squamous intraepithelial neoplasia.